C 반응성 단백질 검사 시장 규모, 점유율, 성장 분석 : 어세이 유형별, 검출 범위별, 질병 영역별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)

Global C-Reactive Protein Testing Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.6 billion in 2023 to USD 5.52 billion by 2031, growing at a CAGR of 2.3% during the forecast period (2024-2031).

The global market for C-reactive protein testing is poised for significant growth, driven by advancements in nanotechnology that enhance specificity, sensitivity, and rapid on-site disease diagnosis. New point-of-care assays for CRP testing are emerging, responding to the increasing demand for swift diagnostic tools. Research from Mohammed VI University highlights CRP's potential in assessing SARS-CoV-2 severity, further cementing its relevance. Additionally, the rising prevalence of inflammatory disorders, diabetes, and cancers, alongside a growing incidence of endometriosis and increased funding in diagnostics, is expected to fuel market expansion. Notably, the CDC reported that over 20.1 million adults in the U.S. suffer from coronary artery disease, a number anticipated to rise, thereby amplifying market opportunities in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global C-Reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global C-Reactive Protein Testing Market Segmental Analysis

Global C-Reactive Protein Testing Market is segmented by assay type, detection range, disease area, end-use and region. Based on assay type, the market is segmented into immunoturbidimetric assay, ELISA, chemiluminescence immunoassay and others. Based on detection range, the market is segmented into HS-CRP, conventional CRP and cCRP. Based on disease area, the market is segmented into cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus and others. Based on end-use, the market is segmented into clinics, hospitals, laboratories, assisted living healthcare facilities, home and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global C-Reactive Protein Testing Market

The global C-reactive protein testing market is poised for significant growth, primarily fueled by the increasing prevalence of cardiovascular diseases. With over 800,000 fatalities attributed to cardiovascular conditions annually in the United States alone, the demand for effective C-reactive protein testing methods is surging. Additionally, the ongoing research and development aimed at enhancing these testing methodologies will further propel market expansion. The combination of an ageing population and a rising incidence of diabetes mellitus also contributes to this upward trend, indicating a robust market potential in the foreseeable future as healthcare providers seek better diagnostic solutions.

Restraints in the Global C-Reactive Protein Testing Market

The global C-Reactive Protein Testing market is likely to face significant restraints primarily due to low awareness about CRP testing and the limited availability of advanced technologies in lower and medium-sized economies worldwide. This lack of knowledge can lead to underutilization of these important diagnostic tools, hindering market expansion. Furthermore, the high costs associated with CRP testing procedures and the substantial initial investments required to establish appropriate setups could further inhibit growth in the market. Together, these factors pose considerable challenges that may slow down the adoption and proliferation of C-reactive protein testing solutions globally during the forecast period.

Market Trends of the Global C-Reactive Protein Testing Market

The global C-Reactive Protein (CRP) testing market is experiencing significant growth, driven by heightened awareness programs and government initiatives aimed at educating the public on chronic disease prevention and treatment. This surge in awareness has led to the widespread integration of CRP testing in routine clinical practices, particularly in developed regions such as the United States, Germany, France, and Japan. As healthcare providers increasingly prioritize CRP tests for assessing inflammation and guiding treatment decisions, the market is poised for robust expansion in the coming years, reflecting a shift towards proactive health management and early disease detection.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global C-Reactive Protein Testing Market Size by Assay Type & CAGR (2024-2031)

• Market Overview
• Immunoturbidimetric Assay
• Elisa
  • Clinical
  • Non-Clinical
• Chemiluminescence Immunoassay
• Others

Global C-Reactive Protein Testing Market Size by Detection Range & CAGR (2024-2031)

• Market Overview
• HS-CRP
• Conventional CRP
• CCRP

Global C-Reactive Protein Testing Market Size by Disease Area & CAGR (2024-2031)

• Market Overview
• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

Global C-Reactive Protein Testing Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Clinics
  • By Entity
  • Physician Offices
  • Small Clinics
  • Others
  • By Settings
  • Urban Setting
  • Rural Setting
• Hospitals
  • Urban Setting
  • Rural Setting
• Laboratories
  • Urban Setting
  • Rural Setting
• Assisted Living Healthcare Facilities
  • Urban Setting
  • Rural Setting
• Home
• Others

Global C-Reactive Protein Testing Market Size & CAGR (2024-2031)

• North America (Assay Type, Detection Range, Disease Area, End-Use)
  • US
  • Canada
• Europe (Assay Type, Detection Range, Disease Area, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Assay Type, Detection Range, Disease Area, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Assay Type, Detection Range, Disease Area, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Assay Type, Detection Range, Disease Area, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boditech Med Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Millipore
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Bioscience Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations